Our improved Xylazine 2.0 does not cross react with lidocaine and is sutable for testing drug samples including cocaine, is now available as a 100 pack.
WARNING: THIS TEST DOES NOT EVALUATE DRUG SAFETY OR PURITY
The Rapid Response™ Xylazine Test Strip (Liquid/Powder) is a rapid visual immunoassay for the qualitative, presumptive detection of xylazine in suspicious substances (liquids or powders) at the cut-off concentration of 1000 ng/mL. For forensic use only. Not an IVD.
The latest update to the Rapid Response™ Xylazine Test Strip (2.0) can be used to test cocaine samples, and has shown no cross reactivity with lidocaine.
RapidReader App
Lateral Flow Scanner
WARNING: THIS TEST DOES NOT EVALUATE DRUG SAFETY OR PURITY
The Rapid Response™ Xylazine Test Strip (Liquid/Powder) is a rapid visual immunoassay for the qualitative, presumptive detection of xylazine in suspicious substances (liquids or powders) at the cut-off concentration of 1000 ng/mL. For forensic use only. Not an IVD.
The latest update to the Rapid Response™ Xylazine Test Strip (2.0) can be used to test cocaine samples, and has shown no cross reactivity with lidocaine.
Results interpretation printed on every pouch
Individually packed strips for easy distribution
Detects Xylazine in concentrations at and above 1000 ng/mL
Results in 60 seconds*
For Liquid or Powder samples
Easy to use with detailed instructions
Xylazine is a non-opioid tranquilizer used as a sedative, analgesic, and muscle relaxant in animals such as horses and cattle[1],[3]. In recent years, xylazine has emerged as an adulterant in recreational drugs such as heroin[2]. Combining xylazine with other drugs that cause central nervous system depression compounds the sedative effects and can increase the risk of overdose and death[2].
References:
[1] GREENE, S.A. and THURMON, J.C. (1988), Xylazine – a review of its pharmacology and use in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 11: 295-313.
[2] Reyes, J.C., Negrón, J.L., Colón, H.M. et al. The Emerging of Xylazine as a New Drug of Abuse and its Health Consequences among Drug Users in Puerto Rico. J Urban Health 89, 519–526 (2012).
[3] Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 2nd ed. Davis: Biomedical Publications; 1982.
- No cross reaction with lidocaine: The test can now be used to test cocaine samples.
- Improved User Guidance: Every pouch features a QR code linking it to the BTNX Harm Reduction Resource Page - giving every user access to written and video instructions.
- Results Interpretation: Results interpretation printed on the back of every pouch and T's and C's printed on each strip to indicate the orientation of the Test and Control lines.
Please refer to the product insert for more details.
Xylazine, originally developed as a veterinary sedative and analgesic, has increasingly become a cause for concern due to its emerging role as a drug of abuse. While primarily intended for use in animals, the drug’s psychoactive properties have led to its illicit use in human populations.
The emergence of Xylazine as a drug of abuse is characterized by its illicit use in combination with other substances, such as opioids, to enhance the effects of these drugs.
This has been observed particularly in certain regions where the availability of xylazine is high. Its sedative and muscle-relaxant properties, when abused, can lead to a range of adverse effects, including respiratory depression, cardiovascular complications, and central nervous system depression.
- Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, Martínez MA. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature. Forensic Sci Int. 2014;240:1-8. doi:10.1016/j.forsciint.2014.03.015
- Meyer GM, Maurer HH. Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn. Anal Bioanal Chem. 2013;405(30):9779-9789. doi:10.1007/s00216-013-7419-7
* A negative result can be interpreted as soon as both the test (T) and control (C) lines appear. A positive result can be interpreted once the control line has appeared and the background has cleared to white, typically by 60 seconds. Do not read results after 10 minutes.
- The test device is NOT intended to determine the purity, composition, or if the substance being examined is safe to use.
- A positive or negative test result is NOT an indication that the substance being examined is safe to use. Many factors come into play when examining the samples, including but not limited to mixture of multiple substances, solubility, and pH of the sample.
- BTNX Inc. does not encourage the use, supply, or production of illegal drugs or controlled substances in any way. The device is intended for harm reduction purposes. Follow the advice of your local harm reduction or public health agency.
- There is a possibility that technical or procedural errors as well as other substances and factors may interfere with the Rapid Response™ Xylazine Test Strip (Liquid / Powder) and cause false results.
- A positive result indicates the presence of xylazine only and does not indicate quantity.
- A negative result does not at any time rule out the presence of xylazine, as they may be present below the minimum detection level of the test.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.
Canada